期刊名称：CELL DISCOVERY ISSN： 2056-5968 出版频率： Continuous publication 出版社： SPRINGERNATURE, CAMPUS, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW   出版社网址： https://www.nature.com/ 期刊网址： https://www.nature.com/celldisc/ 影响因子： 10.849 主题范畴： CELL BIOLOGY;    China Journals 变更情况： 期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)    About the journal Cell Discovery is an open access international journal that publishes results of high significance and broad interest in all areas of molecular and cell biology. Cell Discovery is established in 2015 as a sister journal of the high profile international journal Cell Research. Cell Discovery, published by Springer Nature in partnership with the Shanghai Institutes for Biological Sciences (SIBS), Chinese Academy of Sciences (CAS), aims to provide an open access platform for scientists to publish their high quality works.  Aims & Scope Cell Discovery, published by Springer Nature in partnership with the Shanghai Institutes for Biological Sciences (SIBS), Chinese Academy of Sciences (CAS), aims to provide an open access platform for scientists to publish their high quality works.  Cell Discovery publishes results of high significance and broad interest in all areas of molecular and cell biology, including (but not limited to) the following topics: cell growth and differentiation signal transduction apoptosis stem cells development immunology neurosciences plant cell biology chromatin modulation epigenetics and transcription The journal has an international authorship and a broad scope in basic life sciences, and is a valued member of Springer Nature’s highly respected family of Molecular Cell Biology journals. Instructions to Authors For Authors & Referees Springer Nature publishes high-quality, independently peer-reviewed research and reviews, as well as comments and news, for the scientific and clinical research communities. Springer Nature uses pioneering technologies, innovative formats and first-class editing to provide cutting-edge, timely yet readable information for researchers in the public and private sectors, government agencies, educators, clinicians and the general public. Springer Nature has a close relationship with the scientific community. By working with scientists, listening to what they say, and always placing emphasis on quality, Springer Nature is the leading publisher for innovative solutions to scientists' information needs. Submit To publish in the journal, please go to the online submission system. Benefits to Authors Articles published in Cell Discovery are open access, allowing for the widest dissemination, visibility, and impact of your research – visit the benefits to authors page to explore the reasons why you should publish with the journal. For Referees To find out more about the criteria for publication and the review process for Cell Discovery, Please visit the for referees page. Editorial Board Editor Dr Gang Pei, Chinese Academy of Sciences, China Executive Editor Dr Dangsheng Li, Shanghai Institutes for Biological Sciences, CAS, China Editorial Board Members Rene Bernards, The Netherlands Cancer Institute, Amsterdam Xuetao Cao, Zhejiang University School of Medicine, Hangzhou Qi Chen, University of California, Riverside Quan Chen, Institute of Zoology, CAS, Beijing Ye-Guang Chen, Tsinghua University, Beijing Kenneth R Chien, Karolinska Institutet, Stockholm Bruce Demple, Stony Brook University School of Medicine, Stony Brook Hongkui Deng, Peking University, Beijing Chen Dong, School of Medicine, Tsinghua University, Beijing Julian Downward, The Francis Crick Institute, London Xin-Hua Feng, Zhejiang University, Hangzhou Jiri Friml, Institute of Science and Technology Austria, Klosterneuburg Xiang-Dong Fu, University of California at San Diego, San Diego Shiv IS Grewal, National Institutes of Health, Bethesda Kun-Liang Guan, University of California at San Diego, San Diego Alexander Hoffmann, University of California at Los Angeles, Los Angeles Tony Hunter, Salk Institute for Biological Studies, San Diego Juan Carlos Izpisúa Belmonte, Salk Institute for Biological Studies, San Diego Peter A Jones, Van Andel Research Institute, Michigan Yibin Kang, Princeton University, Princeton Guido Kroemer, INSERM, Paris Tatiana Kutateladze, University of Colorado Anschutz Medical Campus, Aurora Paul Lasko, McGill University, Montreal Steven C Ley, The Francis Crick Institute, London Guo-Min Li, University of Kentucky College of Medicine, Lexington Jiayang Li, Institute of Genetics and Developmental Biology, CAS, Beijing Lin Li, Shanghai Institutes for Biological Sciences, CAS, Shanghai Xiaolong Liu, Shanghai Institutes for Biological Sciences, CAS, Shanghai Zheng-gang Liu, National Institutes of Health, Bethesda Sheng Luan, University of California at Berkeley, Berkeley David C Lyden, Cornell Medical College, New York Gerry Melino, University Tor Vergata, Rome Anming Meng, Tsinghua University, Beijing Kohei Miyazono, University of Tokyo, Tokyo Bernd Mueller-Roeber, University of Potsdam, Potsdam-Golm Andrea Musacchio, Max Planck Institute of Molecular Physiology, Dortmund Huck-Hui Ng, National University of Singapore, Singapore Michele Pagano, New York University School of Medicine, New York Duanqing Pei, Guangzhou Institutes of Biomedicine and Health, CAS, Guangzhou Kathrin Plath, University of California Los Angeles, Los Angeles Yang Shi, Harvard Medical School, Boston Yigong Shi, Tsinghua University, Beijing Hong-Bing Shu, Wuhan University, Wuhan Shao-Cong Sun, University of Texas MD Anderson Cancer Center, Houston M Azim Surani, Wellcome Trust Cancer Research UK Gurdon Institute, Cambridge Claire E Walczak, Indiana University, Bloomington Xiao-Fan Wang, Duke University Medical Center, Durham Yongna Xing, University of Wisconsin-Madison, Madison Xuebiao Yao, University of Science & Technology of China, Hefei Gene W Yeo, University of California at San Diego, San Diego Xu Zhang, Shanghai Institutes for Biological Sciences, CAS, Shanghai Yi Zhang, Harvard Medical School, Boston Yixian Zheng, Carnegie Institution of Washington, Baltimore